Glaxo to put 4 new cancer drugs into final trials (Reuters)
30th Nov 2005, 22:54 GMT
Reuters - GlaxoSmithKline Plc will put four new cancer drugs into final-stage clinical trials next year, as it sets its sights on a leading position in the drug industry's fastest-growing market.
Glaxo to put 4 new cancer drugs into final trials (Reuters) related news:
- Glaxo sees 4 cancer drugs in final trials in 2006 (Reuters) — Yahoo! News: Health News
- Glaxo to put 4 new cancer drugs into final trials — Reuters: Health
- Glaxo to put cancer drugs into final trials — Reuters: Business
- Glaxo sees 4 cancer drugs in final trials in 2006 — RedOrbit News - Health
- Glaxo Bullish on Cancer Drugs — Red Herring
- Glaxo Highlights Tykerb Cancer Drug — WSJ.com: US Business
- GSK in drive for new cancer drugs — Business
- Too Many Cancer Patients Continue to Smoke (HealthDay) — Yahoo! News: Health News
- GSK presents positive cancer drug data — FT.com / Home UK
- Glaxo looks to become cancer drug leader — CNNmoney.com - International News
Latest news from Yahoo! News: Health News:
- Health care costs could jump 10 percent (AP)
- Results mixed on Merck's new painkiller (AP)
- More South Africans get AIDS medicine (AP)
- Europe to draw up strategy against obesity (AFP)
- Clinical Trials Update: Nov. 13, 2006 (HealthDay)
- Pharmacy Program Helps Elderly Take Their Meds (HealthDay)
- Red meat may raise breast cancer risk (AP)
- Insurers' plan aims to cover uninsured (AP)
- FDA: Tamiflu patients need monitoring (AP)
- Flu Drug Tamiflu May Cause Odd Behavior in Children (HealthDay)